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Identification of Persistent Defects in Insulin Receptor Structure and Function
in Capillary Endothelial Cells from Diabetic Rats
Ching Fai Kwok, Barry J. Goldstein, Dirk Muller-Wieland, Tian-Shing Lee, C. Ronald Kahn, and George L. King

Research Division, Joslin Diabetes Center, Department ofMedicine, Brigham and Womens Hospital, and Harvard Medical School,
Boston, Massachusetts 02215

Abstract
Insulin actions and receptors were studied in capillary endothelial cells cultured from diabetic BB rats and their nondiabetic
colony mates. The endothelial cells from diabetic rats of 2 mo
duration had persistent biological and biochemical defects in
culture. Compared with normal rats, endothelial cells from
diabetic rats grew 44% more slowly. Binding studies of insulin
and insulin-like growth factor I (IGF-I) showed that cells from
diabetic rats had 50% decrease of insulin receptor binding
(nondiabetic: 4.6±0.7; diabetic: 2.6±0.4% per milligram protein, P < 0.01), which was caused by a 50% decrease in the
number of binding sites per milligram protein, whereas IGF-I
binding was not changed. Insulin stimulation of 2-deoxy-glucose uptake and a-aminoisobutyric acid uptake were also severely impaired with a 80-90% decrease in maximal stimulation, in parallel with a 62% decrease of insulin-stimulated autophosphorylation (P < 0.05). 125I-insulin cross-linking
revealed an 140-kD a subunit of the insulin receptor similar to
that in cells from nondiabetic rats, although bands at > 200 kD
were also detected. The molecular weight of the insulin receptor,8 subunit (by SDS-PAGE) was smaller in cells from diabetic than from normal rats (88-90 vs. 95 kD). Neuraminadase
treatment of the partially purified insulin receptors decreased
the molecular weight of the insulin receptors from nondiabetic
rats to a greater degree than its diabetic counterpart. In contrast, Northern blot analysis of insulin receptor mRNAs using
human cDNA probes revealed two species of 9.4 and 7.2 kb
with no difference in mRNA abundance between cells from
diabetic and nondiabetic rats. We conclude that the exposure
of capillary endothelial cells to a diabetic milieu in vivo can
cause specific and persistent changes in the insulin receptor
and insulin action.

Introduction

Microangiopathy is a major cause of morbidity in patients
with diabetes mellitus. The pathogenesis of diabetic microangiopathy remains enigmatic, despite the acquisition of a great
deal of knowledge concerning functional (1-3), biochemical
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(4), and morphological changes (5) in the vasculature of diabetic patients. These characteristic changes include increased
regional vascular flow (1, 2), increased microvascular permeability (3), capillary basement membrane thickening (4), and
the presence of microaneurysms and neovascularization (5). It
is likely that endothelial cells play an important role in the
development of microangiopathy. Cellular abnormalities in
growth have been reported previously in fibroblast and arterial
smooth muscle cells cultured from diabetic animals and patients (6-8), but specific biochemical abnormalities have not
been identified in the vascular cells. Moreover, no study has
characterized the abnormalities of capillary endothelial cells
from diabetic human or animals. Abnormalities in insulin actions and receptor functions have recently been found in nonvascular tissues isolated from diabetic humans and animals
(9-12). Because capillary endothelial cells have been shown
previously to be insulin sensitive (13), abnormalities in these
cells from diabetic animals may also occur.
This study is a comparative analysis of capillary endothelial cells from diabetic and nondiabetic rats with respect to
growth and insulin action, using BB and streptozotocin-induced diabetic rats. In the BB rat model of autoimmune insulin-dependent diabetes, 60% of the BB rats develop clinical
ketosis prone diabetes at the age of 60-100 d (14). A decrease
in the retinal pericyte/endothelial cell ratio and thickening of
capillary basement membrane similar to those reported in diabetic patients have been observed (15, 16). In this work, we
find a persistent biochemical abnormality in the insulin receptor and insulin action of cultured capillary endothelial cells
from diabetic rats.
-

Methods
Materials. Tissue culture plasticware were obtained from Costar Corp.
(Cambridge, MA). DME and Earle's media were from Irvine Scientific
(Santa Ana, CA). Plasma-derived horse serum was from HyClone Laboratories (Logan, UT). Fibronectin and oligo (dT)-cellulose (type III)
were purchased from Collaborative Research (Lexington, MA); collagenase was from Worthington Biochemicals (Freehold, NJ). '25I-A 14insulin, '25I-IGF-I, methyl-[3H]thymidine, and ['4C]2-deoxy-glucose
were purchased from Amersham Corp. (Arlington Heights, IL); porcine insulin was from Elanco (Indianapolis, IN); insulin-like growth
factor I (IGF-I)' was from Imcell (Terre Haute, IN); and ['4C]aamino-isobutyric acid was from New England Nuclear (Boston, MA).
Disuccinimidyl suberate (DSS) was purchased from Pierce Chemical
Co. (Rockford, IL). BioTrace RP Nylon paper was from Gelman
Sciences, Inc., (Ann Arbor, MI). SP 64 vectors were from Promega
Biotec (Madison, WI). Hexamer priming kit Prime Time was from
International Biotechnologies (New Haven, CT). Reagents for electrophoresis were obtained from Bio-Rad Laboratories (Rich1. Abbreviations used in this paper: DSS, disuccinimidyl suberate;
IGF-I, insulin-like growth factor 1; 2-DG-2-deoxy-D-glucose; WGA,
wheat-germ agglutinin.
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mond, CA), and other reagents were from Sigma Chemical Co. (St.
Louis, MO).
Diabetic rats. The animals used in this study were BB rats obtained
from Dr. Arthur Like, University of Massachusetts, Worcester, MA.
Diabetic animals were diagnosed on the basis of 4+ glycosuria and a
plasma glucose in excess of 200 mg/dl. Five groups of diabetic BB rats
(six rats per group) were studied. All diabetic rats were treated with a
single daily injection of protamine zinc insulin suspension with the
dose of insulin adjusted daily to prevent ketonuria and severe weight
loss. Their mean age of death was 160 d, range 146 to 177 d. The mean
duration ofdiabetes was 54 d, range from 42 to 67 d. The mean plasma
glucose value of diabetic rats on the day of death was 364 mg/dl (range
339 to 400 mg/dl).
Nondiabetic control rats. Five groups of nondiabetic rats (six rats
per group) were used as controls. They were all derived from diabetic
forebears. One group (six rats), through inbreeding, is composed of
diabetic-prone BB rats that are now resistant to the disease. The other
four groups (24 rats total) were diabetic-prone as the diabetic BB rats
and were from the colony mates of the diabetic rats, except they had
not developed diabetes at the time of killing. Because diabetic resistant
groups and diabetic-prone groups behave the same with respect to
insulin actions and receptor binding, they were considered together in
this study. Cultures were prepared from these rats at the age of 130-150
d, comparable to the diabetic groups.
Streptozotocin-induced diabetic rats. Sprague-Dawley rats weighing 175-200 g were treated with 70 g/kg wt streptozotocin. All rats with
glucose > 300 mg/dl were designated as diabetic and 50% of the diabetic rats survived for 8 wk without the use of insulin. Six rats with and
without diabetes were maintained for 8 wk and then killed. The capillaries were isolated as described below.
Capillary endothelial cell cultures. Cells were prepared from epididymal fat pads of rats killed with an overdose of CO2 using a method
similar to the one described for retinal endothelial cells ( 13). Briefly,
the fat pads were dissected and minced into small pieces and incubated
with 0.2% collagenase in a PBS. This mixture was homogenized and
centrifuged with the supernatant discarded. The pellet was resuspended in Earle's medium and filtered through three nylon screens of
decreasing mesh sizes of 210, 88, and 53 jim. Digested capillaries
retained by the last nylon screen were collected by centrifugation and
plated on fibronectin-coated tissue culture dishes in DMEM containing 100 mg/dl of glucose with 5% plasma-derived horse serum. The
cells were then harvested by treatment with 0.05% trypsin with 0.2%
EDTA and replanted in fibronectin-coated tissue culture dishes. The
cell identity and the homogeneity of the culture were confirmed by
phase-contrast microscopic morphology and the presence of Factor
VIII antigen by immunofluorescence with specific antibodies (17). No
significant differences in growth or characteristics of insulin receptor
were found between cells from the 5th to 30th passage, which were
used in these studies. For cells used in testing the effect of elevated
glucose level, endothelial cells were incubated in 400 mg/dl of D-glucose for 3-10 mo with the media changed every 2-3 d.
Growth parameters. Cell growth rates were measured by seeding
the same number of trypsinized cells into 12-well (4.9 cm2) plates and
cell counts were made 24 h later and every other day for the course of
the experiment. Cells were counted in an electronic cell counter
(Coulter Electronics, Hialeah, FL) after trypsin dissociation.

Binding studies. Binding of 1251-insulin to capillary endothelial cell
monolayers of diabetic and non-diabetic BB rats was measured as
described previously (18). Briefly, confluent cell monolayers in 6-well
plates were washed with Hepes buffer, pH 7.6, and then incubated for 4
h at 15°C, with 1 ml of Hepes buffer containing 0.5% BSA, 0.15 ng/ml
of '25I-insulin (specific activity 350 ;tCi/;tmol) and various concentrations of unlabeled insulin. The specific binding of '25I-insulin was
calculated by subtracting the amount of radioactivity bound in the
presence of a high concentration of unlabeled porcine insulin (1.6
X 10-6 M) from the total radioactivity bound to cells. Protein content
was determined in duplicate by method of Lowry et al. (19). The same
procedure was used to measure the binding of '251-IGF-I.
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Determination of2-deoxy-D-glucose (2DG) uptake (20). Cell monolayers were rinsed twice with PBS and incubated in DME with 0.5%
BSA for 12 h and then incubated in glucose-free DME for 2 h at 370C
in humidified 5% CO2, and 95% air. The cells were washed with PBS
and then incubated with Krebs-Ringer phosphate-2.5% BSA with or
without various concentrations of insulin for 30 min. ['4C]2DG (0.5
jiCi/well) was then added to the cells and incubated for 10 min. The
radioactive medium was removed and cells washed with ice-cold PBS
three times. The cells were solubilized with 1 ml 0.1% SDS and
counted in liquid scintillation counter (1215 Rackbeta II; LKB Instruments, Gaithersburg, MD). The data were normalized to protein concentration.
Determination of a-amino isobutyric acid (AIB) uptake (21). Cultured endothelial cells were rinsed with PBS and incubated in DME
with 0.5% BSA at 370C for 12 h as previously described (21). After
washing and incubating for another 4 h in PBS with 0.5% BSA and 5
mM glucose in the presence or absence of various concentrations of
insulin, [14C]AIB (0.5 jCi/well) was added to the mixture. After 1 h,
the medium was quickly aspirated and the cells were washed three
times with ice-cold PBS and solubilized with 0.1% SDS. The cell extract was counted in a scintillation counter.
[3H]Thymidine incorporation into DNA. Endothelial cells were
grown to confluence at 370C in 12-well plates (4.9 cm2/well). The
growth media was then replaced with DME containing 0.5% BSA for
24 h. The indicated hormones were added to each well and incubated
for 18 h before pulsing with [3H]thymidine, 2 juCi/ml for 30 min at
370C. The cells were then solubilized in 0.1% SDS and precipitated
with 10% cold TCA and counted in liquid scintillation fluid (22).
Affinity labeling (23). Binding was performed with '251-insulin (2.5
ng/ml, 350 ;tCi/mmol) at 1 5'C for 4 h in the presence and absence of
unlabeled insulin as described previously using DSS. The cell lysates
were boiled in Laemmli solution containing 0.1 M DTT and then
analyzed in 0.1% SDS, 7.5% polyacrylamide gels using a discontinuous
system with molecular weight standards of myosin, 200,000; (3-galactosidase, 116,250; phosphorylase B, 92,500; BSA 66,200; and ovalbumin, 45,000. The gels were stained with 0.25% Coomassie brilliant
blue and autoradiographed with Kodak X-Omat film for 3 wk.
Insulin receptor phosphorylation. The insulin receptor autophosphorylation assay was performed using Triton X-100 to solubilize the
cells, and purification of the receptor on a wheat-germ agglutinin
(WGA) agarose column (24). The partially purified receptor after normalization for insulin binding was incubated with different concentrations of insulin for 30 min at room temperature in the presence of 5
mM MnCI2. The phosphorylation reaction was initiated by adding 50
juM cold ATP and 100 jCi/tube 32P-ATP. After 8 min, the reaction was
stopped by the addition of cold solution containing 50 mM NaF, 20
mM Na4P2O7, 5 mM EDTA, and 50 mM ATP and then immunoprecipitated with antireceptor antibody (serum B9 at 1:200). The immune
complexes were precipitated with protein A (Calbiochem-Behring
Corp., La Jolla, CA). After being washed three times, the pellets were
solubilized and boiled in Laemmli buffer and submitted to SDS, 7.5%
PAGE under reducing conditions (0.1 M DTT). The phosphorylated (3
subunit of the insulin receptor was identified by autoradiography and
quantitated by scanning densitometry of the autoradiograms.
Neuraminidase treatment of insulin receptors was performed by
incubating WGA-purified receptors with 2 U/ml neuraminidase at
37°C for 30 min in the presence of 0.1 mg/ml aprotinin. Autophosphorylation and identification of insulin receptor (3 subunits was then
performed as described above.
Northern blot analysis of insulin receptor mRNA. Endothelial cell
RNA was isolated by the method of Han et al. (25) and poly(A)+ RNA
was selected by two passages over oligo(dT)-cellulose (26). Poly(A)+
RNA was then separated on a 1% agarose-2.2 M formaldehyde gel and
transferred to BioTrace RP Nylon paper with lOX SSC (I X SSC = 0.15
M NaCl/0.01 5 M Na citrate). Filters were baked at 80°C for 2 h,
soaked at 65°C for I h in 0.1 X SSC/0.5% (wt/vol) SDS, and then
prehybridized at 42°C for 16 h in a solution containing 50% formamide, 10% dextran sulfate, 0.45 M NaCI, 1% (wt/vol) SDS, 0.5%

(wt/vol) nonfat dry milk, 0.5 mg/ml denatured salmon sperm DNA, 3
mM EDTA, 30 mM NaH2PO4 buffer, pH 7.4. Human insulin receptor
cDNA fragments Eco RI 1,01 1 and 4,187 bp (27) were generously
provided by Dr. Ora Rosen (Memorial-Sloan Kettering Cancer Center,
New York, NY) and subcloned in SP 64 vectors. A 677-bp probe for
the insulin receptor a subunit was generated by Xho I digestion of the
1,01 l-bp Eco RI fragment; a 1,599-bp probe for the 6 subunit was
similarly produced by Pst I cleavage of the 4,187-bp Eco RI fragment.
Probes were labeled with a-[32P]-dCTP to _1 X 109 dpm/ug using a
random hexamer priming kit. Hybridization was for 16-20 h at 420C
in prehybridization solution. Blots were washed successively in 2X
SSC, 0. 1% SDS, 0.5X SSC, 0.1% SDS and 0.1 X SSC, 0.5% SDS at room
temperature followed by 0.1 X SSC, 0.5% SDS for 30 min at 50'C
before autoradiography at -80'C.
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Growth parameters. The growth characteristics of the endothelial cells from the diabetic and nondiabetic rats were compared. For cells derived from nondiabetic BB rats, the average
doubling time was 18±1.3 h and the cell density at confluency
was (16.7±2.2) X 104 cells/cm2 (mean and SD of three independent cell isolates). In contrast, endothelial cells from the
diabetic animals grew slower, with a doubling time of 32.3±4.7
h (P < 0.01) and had fewer cells at confluency (11.9±0.9)
X 104 cells/cm2 (Table I). A similar decrease in growth rate was
observed in the cells harvested from streptozotocin-treated diabetic rats.
Biological effects ofinsulin. Because endothelial cells from
the adipose tissue and other microvessels have been shown to
be sensitive to insulin and IGF-I stimulation (13), the responsiveness of the endothelial cells from the diabetic and nondiabetic BB rats to insulin as measured by 2DG and AIB uptake
was determined. Capillary endothelial cells from nondiabetic
rats showed an increase of 2DG uptake when stimulated by
insulin at 0.16 nM and reached the maximum of 180% of basal
at 160 nM (Fig. 1). Surprisingly, in cells from diabetic animals
there was no stimulation of 2DG uptake by insulin at any
concentration (Fig. 1). Similarly, capillary endothelial cells
from streptozotocin-treated rats did not respond significantly
to insulin stimulation. Spermidine, which has been shown to
increase glucose uptake into cells via a pathway that is probably distal to the insulin receptors had a similar stimulation of
2DG (50-70% maximum, n = 3) uptake in both diabetic and
nondiabetic cells (data not shown).
In addition to glucose uptake, insulin's effect on amino
acid uptake was measured using [14C]AIB with cells from nondiabetic rats, some stimulation of uptake was observed with an
insulin concentration of 0.16 nM and uptake reached its peak
at 160 nM (Fig. 2), in parallel with 2DG uptake. By contrast,

Figure 1. Dose response of insulin-stimulated 2DG uptake by capillary endothelial cells from (o) diabetic and (.) nondiabetic BB rats.
2DG uptake was performed as described in Methods. Each point
represents the mean and SE from three separate experiments using
endothelial cells from three different groups of diabetic and nondiabetic BB rats. The difference in 2DG uptake between endothelial
cells from diabetic and nondiabetic BB rats is significant at insulin
concentrations of 1.6 X I0-' M with a P value < 0.01 as analyzed by
the paired t test.

cells from the diabetic animals did not show any significant
effect at any insulin concentration (Fig. 2).
[3H] Thymidine incorporation into DNA. The growth effects of insulin and IGF-I were studied by measuring [3H]thymidine incorporation into DNA. In previous studies, insulin was reported to be less potent then IGF-I (13, 28). These
findings are confirmed in this study. Insulin at 9 X I 0- M
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Table L Growth Parameters in Capillary Endothelial
Cells from BB Rats

Doubling time (h)
Cell density at confluency

(1J0 cells/cm2)

Nondiabetic

Diabetic

P

18.03±1.3

32.33±4.7

<0.01

16.7±2.3

11.9±0.9

0.06

P values were derived by paired t test. Data shown here are
mean±SD from three experiments.
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Figure 2. Dose response of insulin-stimulated a-amino-isobutyric
acid uptake by capillary endothelial cells from (o) diabetic and (-)
nondiabetic BB rats. a-Amino-isobutyric acid uptake was performed
as described in Methods. Each point represents mean and SE from
three separate experiments using endothelial cells from three different groups of diabetic and nondiabetic BB rats. The differences in
AIB uptake between endothelial cells from diabetic and nondiabetic
BB rats are significant at insulin concentrations of 1.6 X 10-6, 1.6
X i0-9, and 1.6 X 10-'0 M with P values < 0.03 as analyzed by the
paired t test.
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Figure 3. Dose response of insulin- and IGF-I-stimulated DNA synthesis as measured by [3H]thymidine
incorporation in capillary endothelial cells from (in)
diabetic and (m) nondiabetic BB rats. [3H]Thymidine
incorporation was performed as described in
Methods. Data shown here are mean and SE from
three separate experiments. The difference between
diabetic and nondiabetic is not significant.

changes. The dose-dependent inhibition of '25I-insulin
by increasing concentration of unlabeled insulin was
in both nondiabetic and diabetic endothelial cells from
with 50% inhibition at 0.8 and 0.6 nM, respectively.
ird analysis of the competition curve showed no change
ity (Ka), but the R. appeared to be lower in cells from
c rats by 50%. By comparison, IGF-I binding was two to
mes greater than insulin binding, but showed no change
from diabetic rats; specific binding was 16.7±1.2 vs.
'% per milligram protein (Fig. 5). No difference was
between cells from diabetic and nondiabetic rats. In
n, fibroblasts from the fatty tissue were also cultured
-ir insulin receptor binding were compared. No signififferences were observed between cells from diabetic and
betic rats, 1.8±0.5 versus 1.4±0.6% milligram protein,
ively (SE, n = 3). Concentrations for 50% displacement
insulin were similar at 1.2 and 1.0 X 10-9 M respecfor diabetic and nondiabetic rats. Scatchard analysis of
rnpetition curve showed the derived R. and Kd did not
etween these two groups of rats. These data suggested

stimulated [3H]thymidine incorporation to the same extent as
4 X 10-8 M of IGF-I. Comparable maximums were obtained
with insulin and IGF-I but at different concentrations. No
difference in both insulin and IGF-I stimulated [3H]thymidine
incorporation was found between cells from diabetic and nondiabetic rats (Fig. 3).
Insulin receptor. Because endothelial cells from diabetic
rats of spontaneous origin (BB) and streptozotocin-induced
rats were less responsive to insulin as compared with cells from
nondiabetic animals, the insulin receptor on these cells was
examined. '251I-insulin binding to cell surface receptors was
decreased when the endothelial cells of diabetic rats were
compared with those of nondiabetic rats. At tracer concentration, the endothelial cells from normal BB rats exhibited a
4.6±0.7% binding per milligram of cell protein, whereas endothelial cells cultured from diabetic rats bound only 2.6±0.4%
per milligram protein, (P < 0.01) (Fig. 4). In cells from
Sprague-Dawley rats, the diabetic and nondiabetic rats had
1.9±0.6 and 3.4±0.4% per milligram protein, respectively.
Scatchard analysis showed the change is due to receptor num-
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Figure 4. Competitive inhibition curves of insulin binding to intact capillary endothelial
cells of (o) diabetic and (-) nondiabetic BB
rats and (A) cells from nondiabetic rats and
treated with high glucose (400 mg/dl) for 1-10
mo in culture. Insulin binding to endothelial
cells was performed as described in Methods.
The specific binding was calculated by subtracting the amount of radioactivity bound in
the presence of 1.6 X 10-6 M (10 4g/ml) of
unlabeled porcine insulin from the total radioactivity bound to cells. Each point represents
mean and SE from five separate experiments

using endothelial cells from five different
groups of diabetic and nondiabetic BB rats.
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that the binding defect in endothelial cells from diabetic rats
specific to insulin receptor.
The insulin receptor a and subunits were further characterized biochemically. The a subunit of the insulin receptor
was examined by affinity cross-linking studies by covalently
coupling bound '25I-insulin to the receptor with DSS and examining the solubilized receptor complexes by SDS-PAGE
and autoradiography. Under reducing conditions (0.1 M
DTT), a band at molecular mass of 140 kD was observed on
the autoradiogram of capillary endothelial cells from both diabetic and nondiabetic BB rats (Fig. 6). This band corresponds
to the a subunit ofthe insulin receptor observed in other endothelial or nonendothelial tissues, although the apparent molecular weight of the receptor in endothelial cells is slightly higher
than that in nonendothelial tissues. In addition, the major
intense band or bands at > 200 kD were found that had been
reported by us previously as cross-linked a subunit of the insulin receptor (30). However, affinity labeling studies using
divalent agents are not quantitative, because of uncertainty of
the cross-linking efficiency in each experiment.
As a 50% decrease ofinsulin binding cannot account quantitatively for the severely impaired metabolic response to insulin in endothelial cells from diabetic BB rats, we further examined the kinase activity of the 1# subunit, which is believed to
initiate some, if not all, of the biological actions of insulin (29).
The protein kinase activity of the subunit of the insulin
receptor was examined using Triton X- 1 00-solubilized and
wheat-germ purified cell extract incubated with 732P-ATP and
Mn2+ in the presence and absence of insulin. The receptors
were then identified by immunoprecipitation with an antireceptor antibody (B9 serum), SDS-PAGE, and autoradiography. A band with a molecular mass of 95 kD that exhibited
insulin-stimulated phosphorylation was observed in cells from
nondiabetic animals (Fig. 7). A variable band at 100 kD can
also be observed and does not appear to be stimulated by
insulin. In contrast, a smaller band at 88-90 kD was observed
in endothelial cells from diabetic animals (Fig. 7). Both bands
are believed to be the subunit of the insulin receptor because
they were stimulated by insulin and precipitated by anti-insulin receptor antibody. Quantitation of autophosphorylation by
densitometric scanning of these bands showed that in nondiawas

-

10-10M)

Figure 5. Competition inhibition curves of IGF-I
binding to intact capillary endothelial cells of (o)
diabetic and (-) nondiabetic BB rats. IGF-I binding to endothelial cells was performed as described in Methods. The specific binding was calculated by subtracting the amount of radioactivity
bound in the presence of 4 X 10-8 M (300 ng/ml)
of unlabeled IGF-I from the total radioactivity
bound to cells. Data shown here are from three
separate experiments, using endothelial cells from
three different groups of diabetic and nondiabetic
BB rats.

betic cells, insulin stimulated the phosphorylation of the rea range of concentrations from 0. 16 to 160 nM,
reaching a maximal on the average at eight times basal (Fig. 8).
Insulin-stimulated phosphorylation of the insulin receptor was
also detected in cells from diabetic BB rats, but only at insulin
concentrations of 1.6 nM or higher, and the maximal stimulation was decreased by 62% (P < 0.05). However, the range of
the decrease is very wide, from 45 to 11%. The concentration
for half-maximal stimulation appears to be higher for the cells
from diabetic animals, although statistically the differences
ceptor over
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Figure 6. Autoradiogram of '25I-insulin-cross-linked insulin receptors
from capillary endothelial cells of nondiabetic (left three lanes) and
diabetic (right three lanes) BB rats. Cross-linking was performed as
described in Methods. The 140-kD band, as shown by the arrow, is
the subunit of insulin receptor. The molecular mass standards used
were: myosin, 200 kD; ,B-galactosidase, 116 kD; and phosphorylase
B, 92.5 kD.
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were not significant because of the large interexperimental
variations found. Table II summarized the findings of insulinstimulated phosphorylation of various preparations of insulin
receptors from capillary endothelial cells of diabetic and nondiabetic BB rats. As shown, both the potency and maximum
amounts of tyrosine phosphorylation of the insulin receptors
in intact cells, whole cell extracts, or wheat-germ purified were
decreased. This loss of activity corresponds to the loss of responsiveness of insulin's metabolic effects, but is greater than
that predicted by the loss of insulin binding.
To determine whether the change in the insulin receptor (3
subunit size is related to altered insulin receptor mRNA ex-

:ij~

103

104

Figure 7. Autoradiogram
of autophosphorylation
of insulin receptor # subunit in wheat-germ partially purified cell extract
from capillary endothelial
cells of nondiabetic (left
six lanes) and diabetic
(right six lanes) BB rats.
Autophosphorylation was
performed as described in
Methods and analyzed by
SDS-PAGE and autoradiography. The bands with
molecular mass of 95 kD
in normal and 88-90 kD
in diabetic are ,3 subunit
of insulin receptor
(arrow). The molecular
mass standards used
were: myosin, 200 kD; ,
galactosidase, 116 kD;
phosphorylase B, 92.5
kD; BSA, 66.2 kD; and
ovalbumin, 45 kD.

pression, Northern blot analysis of insulin receptor mRNAs in
endothelial cells from control and diabetic BB rats was performed. Two mRNA species of 9.4 and 7.2 kb were revealed
using an a subunit sequence probe (Fig. 9). Identical hybridization was observed when this blot was washed and rehybridized with a (3 subunit sequence probe (data not shown). For
cells from both control and diabetic animals, the two receptor
mRNA species are present in the same relative amounts (the
9.4-kb species representing 30% of total receptor mRNA). No
abnormal mRNA species could be detected in the cells from
diabetic rats. Receptor mRNA abundance was also identical
for each cell line when expressed by densitometric scanning
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Figure 8. Dose response curves of insulin receptor autophosphorylation using partially purified receptor from capillary endothelial cells
of (o) diabetic and (-) nondiabetic BB rats.
The bands correspond to , subunit in the autoradiograms were quantitated by densitometric scanning and expressed in arbitrary unit.
The data shown here are average from two
separate experiments. More than five other experiments using different preparations of partially purified insulin receptor from endothelial cells from other groups of diabetic BB rats
showed the same degree of impairment in
maximal stimulated (insulin concentration:

1.6 X
tion.

l0-7 to 1.6 X 10-6 M) autophosphoryla-

Table II. Summary of Insulin Receptor A utophosphorylation
in Capillary Endothelial Cells from Diabetic (DM)
and Normal (NL) BB Rats
Type of insulin receptor preparation for phosphorylation
(fold increase, mean±SE)

Intact cell

Insulin
concentration

DM

NL

Whole cell extract
NL

DM

WGA punfied
NL

DM

ng/ml

10
100
1,000
10,000

0
0
1±1
4±2
7±3* 4±3
8±2* 4±2
n=4

2±1
0
4±2
2±2
7±4
6±3
9±2* 4±2*
n=10

3±1
1±1
4±2
2±1
6±2
3±2
7±2* 3±2*
n=5

The method for the studies and the preparation of receptors were described in Methods.
* P < 0.05
by t test.

units per microgram of poly(A+) RNA applied to the gel (437
U/ug for control cells vs. 450 U/ag in diabetic rat-derived
cells). The nature of the two mRNA species is not currently
known. However, these two bands are identical to those observed in a variety of rat tissues (31), and probably differ in 5'
or 3' untranslated sequences. These findings indicate that there
is no major alteration of insulin receptor mRNA structure or
abundance in the cells from diabetic animals.
Effect of neuraminidase on the size of insulin receptors.
Since the Northern analysis suggested that the protein cores

o
Z

9.4 Kb
7.2 Kb-

_.

Figure 9. Northern blot
analysis of endothelial
cell insulin receptor
FmRNA species. ElectroUi
az
phoresis of Poly(A)+
M
RNA in 1% agarose-2.2
M formaldehyde gels
0
was followed by transfer
to nylon paper and hybridization with a labeled 677-bp Xho I
fragment of the receptor
a subunit coding sequence. Autoradiography was for 3 d. Lane
A, 45 Ag of Poly(A)+
RNA from control BB
rat endothelial cells.
Lane B, 80 ,g of
Poly(A)+ RNA-from diabetic BB rat endothelial cells. Molecular
weights were estimated
using an RNA ladder
with fragments of 9.5,
7.5, 4.4, and 2.4 kb (Bethesda Research Laboratories, Gaithersburg,
MD).

are not significantly different, we evaluated the possibility that
the carbohydrate side chain could be altered. Neuraminidase is
an exoglycosidase that removes the terminal sialic acid residues from the carbohydrate moiety of glyco-proteins. When
digested with neuraminidase, the : subunit of the insulin receptors from cells of nondiabetic rats had a decrease of molecular weight from 95 to 88 kD, whereas a much smaller change
was observed for cells of diabetic rats, 90 to 88 kD (Fig. 10).

Effect of hyperglycemia on insulin binding and receptor
function. Because elevated glucose levels have been reported to
alter the growth properties of endothelial cells (32), we examined the possibility that chronic hyperglycemia in vivo may be
a causal factor for the alteration of the insulin receptor's binding and function. Capillary endothelial cells were exposed to
400 mg/dl of glucose for 3-10 mo and their insulin receptors
were characterized by binding (Fig. 4), phosphorylation, and
function with respect to 2DG uptake. As shown in Fig. 4 and
Table III, elevated glucose at this level did not alter the properties of insulin receptors. In addition, the growth of capillary
endothelial cells exposed to glucose levels of 100 and 400 mg%
did not differ, even after 10 mo of exposure.

Discussion
The pathogenesis of diabetic microangiopathy appears to be
metabolic, because the severity of the retinopathy is associated
with glycemic control ofdiabetic patients over a chronic duration (34). Genetic susceptibility may still play a role, however (35).
This study represents the first report on capillary endothelial cells from animals with diabetes. Cells from diabetic BB
rats were found to have a slower growth rate than the nondiabetic controls, consistent with previous studies (6, 7, 36) reporting altered growth properties in fibroblasts cultured from
diabetic patients, although contrasting findings have also been
reported (37, 38). Interestingly, smooth muscle cells cultured
from diabetic BB rats have been shown to have a more rapid
growth rate and greater density at confluence (8). The reason
for this discrepancy is unknown, although factors such as disease heterogeneity, duration, and difference in the types of
cells used, could be responsible. The simultaneous findings of
abnormalities in cellular growth and insulin actions could be
coincidental. Alternatively, it is also possible that they are
closely associated, since the absence of an insulin effect could
be part of a general loss of nutrient uptake functions, such as
glucose and amino acid transport, which are needed for cellular proliferation.
Surprisingly, the studies on the endothelial cells from diabetic BB rats cultured for up to 30 passages still manifested
abnormalities in receptor sizes and function. The decrease in
receptor binding is due to a decrease in total number ofsurface
binding sites per milligram protein. Furthermore, the changes
are not due to exposure to elevated glucose levels directly because chronic incubation of endothelial cells in high glucose
medium did not reproduce this defect. It is possible that the
decrease of insulin receptor could be due to 2 mo of insulin
treatment before the diabetic rats were killed. However, this is
unlikely since the decrease in binding remained in the capillary endothelial cells after long-term culturing. In addition, the
cells from streptozotocin-induced diabetic rats also showed
decrease in insulin-binding and action though insulin treatment was not used.
Insulin Receptor Defects in Endothelial Cells of Diabetic Rats
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Figure 10. Effect of neuraminidase on WGA-purified insulin receptor ft subunit of endothelial cells from diabetic and nondiabetic BB
rats. The details of the study is described in Methods. Receptors
from nondiabetic rats with (lane 1) and without (lane 3) neuraminidase treatment. Lanes 2 and 4 represented receptors from diabetic rats.

The decrease in the receptor number is also reflected in
insulin metabolic effects as measured by 2DG and AIB uptakes, estimating glucose and amino acid uptake, respectively.
Endothelial cells from nondiabetic rats and bovine have been
shown to be sensitive to insulin for metabolic effects, such as
glucose transport, glucose incorporation into glycogen,- and
amino acid transport (13, 40). In contrast, Corkey et al. (41)
Table III. Effect ofHigh Glucose on Insulin Action and Receptor
in Cultured Capillary Endothelial Cells from Nondiabetic BB Rats
Glucose concentration

Insulin binding
Total (%/mg)
50% displacement (nM)
Insulin stimulated 2-DG uptake
Maximal (ratio to basal)
50% stimulation (nM)
Molecular weight of insulin receptor
(by SDS-PAGE)
a subunit (kDj)
i8 subunit (kD)
Insulin-induced autophosphorylation
Maximal (ratio to basal)
50% stimulation (nM)*

100 mg/dl

400 mg/dl*

4.6±0.7

5.1±0.2

0.8

1.1

1.8

1.4

3.4

3.8

140

95
8.5
250

140
95

5.2
125

* Cells had been exposed to high glucose concentrations (400 mg/dl)
for 3-10 mo.
Higher insulin concentration was needed to achieve 50% stimulation because crude cell extracts were used instead of the partially purified receptor.
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demonstrated that insulin did not influence hexose uptake in
normal or transformed human umbilical vein endothelial cells
and arterial endothelial cells, suggesting endothelial cells from
capillary and arterial sources respond to insulin in different
ways. In fact, King et al. (40) have reported differential responsiveness to insulin'ofendothelial cells from bovine macro- and
microvessels when studied under the same conditions.
Insulin's effects on both glucose and amino acid uptake
were severely impaired in endothelial cells from diabetic rats as
compared with normal rats. Because spermidine's effect on
inducing 2DG uptake is normal, the defect in the endothelial
cells from diabetic rats is probably not due to alteration in the
glucose transportation but located in or near the insulin receptors. However, the defects in insulin-stimulated metabolic effects cannot be accounted for by the decrease in insulin binding alone, since both the insulin sensitivity and responsiveness
were impaired to a much greater degree than binding defects,
suggesting the presence of postbinding defects (42) in endothelial cells from diabetic rats. This was further confirmed by the
finding that the insulin-stimulated phosphorylation of the ,
subunit of insulin receptor, one of the earliest events that
occurs upon binding of insulin (43), was also decreased in
endothelial cells from diabetic rats to a greater degree and
comparable to the defect observed in insulin's effect. Since the
defect in phosphorylation correlates in severity with the loss of
metabolic effects of insulin, this postbinding defect could be
responsible for the impairment of metabolic effects of insulin,
although postreceptor defects were not excluded.
In contrast to the severe impairment of the metabolic actions of insulin (2DG and AIB uptake) found in diabetic cells,
the growth promoting effects of insulin as measured by [3H]thymidine incorporation was not different when cells from
nondiabetic and diabetic rats were compared. This could be
partly explained by the presence of unaltered IGF-I receptors
on the endothelial cells, because the growth-promoting effects
of insulin in endothelial cells may be mediated through the
IGF-I receptor, which insulin can bind at with low affinity (13,
44-46). The finding that IGF-I is apparently more potent than
insulin supports this possibility. However, more studies are
needed to confirm this speculation. Since in other capillary
endothelial cells, insulin can be equally potent with IGF-I in its
mediating growth effects (13). We are providing these data to
show that not all the actions of insulin are affected in endothelial cells from diabetic rats.
The differences found between the cells from diabetic and
nondiabetic rats may have occurred before the rats developed
diabetes. Because the diabetic rats were derived from the same
parents as the control rats and contained the same genetic
material, this possibility is not likely, although not completely
excluded. To answer this question, characterization of insulin
action and its receptor in capillary endothelial cells from rats
rendered diabetic with streptozotocin will be helpful and is
currently in progress. An alternate explanation for these differences is that the culturing procedures may have resulted in
the isolation of a subpopulation of insulin resistant endothelial
cells from diabetic rats. This possibility is minimized but not
excluded by using cells from multiple preparations from a
large number of rats, all of which showed similar findings in
both early and late passages (5th to 30th). In addition, the cells
from diabetic rats were cultured under the same conditions as
the nondiabetic cells. We thus would conclude that the differences between the cells were present before the in vitro cultur-

ing of cells and postulate that the diabetic milieu in vivo has
converted the capillary endothelial cells from an insulin-sensitive to -resistant state.
The alterations of insulin binding and action, and decreased tyrosine kinase activity were also found to be associated with a change in the /3 subunit electrophoretic mobility
migration rate, suggesting changes in its structure. This association could be coincidental. However, it is also possible that
the decrease in size of # subunit is responsible for the defects in
insulin binding, action and phosphorylation. The difference in
/3 subunit size is apparently not due to a major alteration in
receptor gene expression, because the Northern analysis
showed no obvious difference between capillary cells from diabetic and nondiabetic BB rats. However, this study does not
rule out small changes in the RNA sequences that may not
alter cDNA hybridization. Translational control and/or posttranslational modifications affecting both size and abundance
of the receptor /3 subunit are more likely to account for the
alterations observed in endothelial cells from the diabetic BB
rats. Posttranslational changes could occur at the level of enzymatic glycosylation of the /3 subunit or other structural modifications of the peptide. The neuraminadase data further supports the likelihood of a posttranslational modifications in the
glycosylation step. Further studies focused on peptide mapping and the carbohydrate moieties of the insulin receptor /3
subunit in capillary endothelial cells from diabetic animals
and patients are in progress. The findings in the endothelial
cells appear to be unusual among the various cells studied in
the diabetic BB rats and other diabetic models. Previous studies by Okamoto et al. (47) did not reveal a molecular size
change but did reveal tyrosine kinase activity changes. In addition, fibroblasts for the diabetic rats did not show any binding alterations. These findings would suggest that the changes
in molecular size and actions of insulin receptors may be
unique in the endothelial cells. Note that the insulin receptor
in endothelial cells has the unusual property of processing insulin for the transcytosis pathway ( 18, 46, 48). It thus would be
tempting to suggest these two processes may be related.
The connection between this loss of insulin regulation in
the capillary endothelial cells from diabetic rats to the development of diabetic microangiopathy will require further studies.
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